General Information of This Antibody
Antibody ID
ANI0UBWKA
Antibody Name
DT390
Antibody Type
Monoclonal antibody (mAb)
Antibody Subtype
Humanized IgG
Antigen Name
C-C chemokine receptor type 4 (CCR4)
 Antigen Info 
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
IL2-CCR4 immunotoxin [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
1.57 pM
Positive CCR4 expression (CCR4 +++/++)
Method Description
In vitro efficacy comparison of the CCR4 IT vs IL2 fusion toxin to human CCR4+ CTCL Hut102/6TG using luminescent cell viability assay.
In Vitro Model Cutaneous T cell lymphoma HUT102/6TG cells Homo sapiens
IL2-CCR4 IT [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Inhibitory Concentration (IC50)
6.30 pM
Positive CCR4 expression (CCR4 +++/++)
Method Description
In vitro efficacy comparison of the CCR4 IT vs IL2 fusion toxin to human CCR4+ CTCL Hut102/6TG using luminescent cell viability assay.
In Vitro Model Cutaneous T cell lymphoma HUT102/6TG cells Homo sapiens
References
Ref 1 Bispecific human IL2-CCR4 immunotoxin targets human cutaneous T-cell lymphoma. Mol Oncol. 2020 May;14(5):991-1000. doi: 10.1002/1878-0261.12653. Epub 2020 Mar 13.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.